Skip to main content

Advertisement

Log in

Physician characteristics associated with the use of bone densitometry

  • Brief Reports
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

To determine physician characteristics associated with the use of bone densitometry (BD), we conducted a cross-sectional survey of primary care practitioners in an urban community hospital. Participants were internists, geriatricians, and family practitioners. Seventy-two percent of the physicians never used BD. There was no association between physician or practice characteristics and BD use. Bone densitometry users were more likely than nonusers to treat their patients with osteoporosis or at risk of developing it. Self-reported barriers to use included cost, unfamilliarity with guidelines, uncertainty with clinical applicability, minimal impact on treatment decisions, and availability. In conclusion, although it has been shown that osteoporotic women who are aware of their BD results are more likely to accept treatment, further attention should be paid to primary care practitioners’ attitudes, knowledge, and behavior regarding the use of BD in the management of osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Peck WA. National Institute of Health Consensus Conference: Osteoporosis. JAMA. 1984;252:799–802.

    Article  Google Scholar 

  2. Baron JA, Barrett J, Berger M. Incidence and costs to medicare of fractures among medicare beneficiaries aged>65 years—US July 1991—June 1992. MMWR. 1996;45:877–8.

    Google Scholar 

  3. Melton JL, Eddy DM, Johnston CC. Screening for osteoporosis. Ann Intern Med. 1990;112:516–28.

    PubMed  Google Scholar 

  4. Johnston CC, Slemenda CW. Risk assessment: theoretical considerations. The consensus development conference on osteoporosis. Am J Med. 1993;95S5A:2–5S.

    Article  Google Scholar 

  5. Wasnich R. Bone mass measurement: prediction of risk. The consensus development conference on osteoporosis. Am J Med. 1993;95S5A:7–10S.

    Google Scholar 

  6. WHO Study Group. Assessment of fracture risk and its application to screening for post-osteoporosis. WHO Tech Rep Theories. 1994:843.

  7. Liberman VA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fracture in postmenopausal osteoporosis. N Engl J Med. 1995;333:1437–43.

    Article  PubMed  CAS  Google Scholar 

  8. Bush TL, Wells HB, James MK, et al. Effects of hormone therapy on bone mineral density: results from the PEPI trial. JAMA. 1996;276:1389–96.

    Article  Google Scholar 

  9. Wahner H. Panel session: bone mass, bone mass measurement, technical aspects and clinical interpretation of bone mineral measurements. Public Health Rep. 1989;104S:27–30.

    Google Scholar 

  10. Tosteson ANA, Rosenthal DI, Melton J, Weinstein MC. Cost effectiveness of screening peri-menopausal women for osteoporosis; bone densitometry and hormone replacement therapy. Ann Intern Med. 1990;113:594–602.

    PubMed  CAS  Google Scholar 

  11. Cummings SR, Browher WS, Grady D, Ettinger B. Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? Ann Intern Med. 1990;113:565–7.

    PubMed  CAS  Google Scholar 

  12. New drugs for osteoporosis. Med Lett. 1996;38:1–3.

    Google Scholar 

  13. Riggs BL, Wahner HW. Bone densitometry in clinical decision making in osteoporosis. Ann Intern Med. 1988;108:293–5.

    PubMed  CAS  Google Scholar 

  14. National Osteoporosis Foundation. Scientific Advisory Board Report. Clinical Indications for Bone Mass Measurements. Washington, DC: National Osteoporosis Foundation, submited to the Health Care Financing Administration: 1989:1–28.

    Google Scholar 

  15. Mazess RB, Barden HS. Bone densitometry for diagnosis and monitoring osteoporosis. Proc Soc Exp Biol Med. 1989;191:261–71.

    PubMed  CAS  Google Scholar 

  16. Johnston CC, Slemenda CW, Melton LJ. Clinical use of bone densitometry. N Engl J Med. 1991;324:1105–9.

    Article  PubMed  Google Scholar 

  17. Genant HK, Block JE, Steiger P, et al. Appropriate use of bone densitometry. J Radiol. 1989;170:817–22.

    CAS  Google Scholar 

  18. U.S. Preventive Services Task Force. Screening for post-menopausal osteoporosis. In: Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Baltimore, Md: Williams & Wilkins; 1989;239–43.

    Google Scholar 

  19. Rubin SM, Cummings SR. Results of bone densitometry affects women’s decisions about taking measures to prevent fractures. Ann Intern Med. 1992;116:990–5.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papa, L.J., Weber, B.E. Physician characteristics associated with the use of bone densitometry. J GEN INTERN MED 12, 781–783 (1997). https://doi.org/10.1046/j.1525-1497.1997.07165.x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1046/j.1525-1497.1997.07165.x

Key words

Navigation